The Capital Brief | ACR, NIC and CPV

We are pleased to share The Capital Network’s summary of the week, including developments in financial markets, media articles, analyst insights, corporate catalysts, and investor engagement events.

The macro picture remained highly fluid over the past fortnight.

In Australia, investors will soon find out whether the blowback received by the Federal Government’s proposed tax changes unveiled Budget night has been enough to force a watering down of these measures as they progress through both houses of parliament.

The past fortnight saw the release of Australia’s April CPI and jobs data. As a package, these stats had more economists calling for the RBA’s benchmark interest rate to be left unchanged at the Bank’s next Monetary Policy Board meeting on 15-16 June.

At the international level, the Middle East conflict remained unresolved, forcing many investors to retain a ‘watch and observe’ stance.

Turning to events in our share market, the past fortnight saw more period ended June reporting companies issue trading updates. A number of these announcements contained profit downgrades that added another layer of volatility to an already skittish local stock market.

On a brighter note, a number of ASX-listed companies has recently issued upbeat announcements that were warmly received by investors always on the lookout for companies successfully implementing their stated growth strategies.

This fortnight’s TCN Newsletter covers three of these companies. All issued announcements that detailed the delivery of either growth strategy milestones or contract wins that are expected to feed through to improved financial performances, either more immediately or further into the future.

Acrux Limited (ASX:ACR)

Acrux Limited (ASX:ACR), a specialty pharmaceuticals company focussed on women’s health, has just announced that the Estradiol spray Lenzetto® it developed will soon enter the Australian market.

This product is already licensed to and marketed in more than 40 countries worldwide by long-time partner Gedeon Richter Plc.

Lenzetto® is a transdermal Estradiol spray which is a hormone replacement therapy (HRT) treatment for symptoms associated with oestrogen deficiency occurring in women after menopause, which include hot flushes.

It uses Acrux’s proprietary Patchless Patch™ technology, a drug delivery system invented at Monash University and designed to provide precise and consistent hormone delivery through a spray rather than patches or tablets.

This development will help address a critical shortage of Menopause Hormone Therapy products in the Aussie market. It has been made possible by the execution of an amendment  to Acrux’s current licensing agreement for Lenzetto® with Gedeon Richter Plc.

Under this amended agreement, Acrux will receive upfront, regulatory, and commercial  milestone payments from Gedeon Richter Plc for Lenzetto® entering the Australian market. Together these payments could total up to A$5.4 million. They will be received within two years from the product’s launch.

These payments place Acrux in a strong position as the Company continues to work towards bringing its innovative Female Testosterone product to market.

Nickel Industries Limited (ASX:NIC)

Nickel Industries (ASX) owns a portfolio of mining and low-cost downstream nickel processing assets in Indonesia. These assets include controlling interests in the world-class Hengjaya Mine, as well as four rotary kiln electric furnace (RKEF) projects, which produce nickel matte for the electric vehicle supply chain and nickel pig iron for the stainless-steel industry.

In late May 2026, Nickel Industrials announced an updated Mineral Resource for a material portion of its Sampala Project, which is located in close proximity to the Company’s existing RKEF and high-pressure acid leach (HPAL) operations within the Indonesia Morowali Industrial Park.

The Sampala Project consists of three advanced, contiguous nickel-cobalt mining concessions covering 6,654 hectares, with the updated Mineral Resource estimate covering two of these three concessions. The new Mineral Resource is 1,095 million wet metric tonnes (wmt) at 1.24% Ni and 0.09% Co (containing 8 million tonnes of nickel and 583 thousand tonnes of cobalt).

The final acquisition payment of US$144 million for a 60% interest in PT Abadi Nikel Nusantara, one of the two Sampala concessions making up the updated Mineral Resource estimate, is due in April 2027.

Looking into the future, Nickel Industries believes there is real potential for further upgrades to Sampala’s Mineral Resource, on the back of pending results from exploration activities in the Project’s third concession.

But even before any such positive development, the just released updated Sampala Project Resource positions Nickel Industries as one of the largest holders of nickel resources across the globe.

The eventual development of the Sampala Project will allow Nickel Industries’ RKEF operations to become fully self-sufficient in saprolite.

ClearVue Technologies (ASX:CPV)

ClearVue Technologies (ASX:CPV) is one of a select number of ASX-listed companies that is unambiguously leveraged to Australia’s inexorable push towards decarbonisation.

It is a technology company that integrates solar technology into building façade and rooftop surfaces to provide renewable energy generation and offset the operational carbon footprint of buildings.

ClearVue Technologies has just announced that it has been selected to supply three bespoke building-integrated photovoltaic (BIPV) products for Canva's new Sydney headquarters. The total expected value of the Canva HQ project is around A$0.6 million.

The ClearVue product families to be deployed under this contract are the ClearVue Solar Skylight, Solar Balustrade and rooftop solar. It will see approximately 310 panels installed across over 660 metres.

The contract requires bespoke engineering across all three of the abovementioned products,  including a custom Balustrade framing system, which conceals all electrical wiring and integrates ClearVue Technologies' latest Thermal Management Junction Box.

Just a few days earlier ClearVue Technologies issued another positive ASX announcement.

This one informed investors that the company had entered the huge Indian market.

This broadening of its geographic footprint was facilitated by the signing of a Manufacturing and Distribution Agreement with Aria Glass Industries Private Limited, a subsidiary of Aria Holding, to manufacture and distribute ClearVue BIPV products in India.

Aria Holding has committed US$240.5M for a new float glass plant in Maharashtra, India, an investment that underpins the scale of the latter group's manufacturing ambitions in the country – one where government renewable energy targets are driving significant demand for BIPV solutions.